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H3PO4Æ12WO3ÆxH2OAbstract In this study H3PO4Æ12WO3ÆxH2O is found to catalyze the preparation of Schiff bases
from the reaction of 3-(1H-Benzimidazol-2-yl)naphthalene-2-amine with different aldehydes efﬁ-
ciently in ethanol. The advantages of this environmental friendly and mild method are such as sim-
plicity of the reaction procedure, the elimination of solvents, simple work-up, high product yields
and short reaction times. The products were characterized by FT-IR 1H NMR, 13C NMR, mass
spectrometry and elemental analysis.
ª 2011 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
In recent years, the use of heterogeneous catalysts have
received considerable interest in various disciplines, including
organic synthesis owing to their easy work-up procedures, easy
ﬁltration, commercially available, environmentally friendly,
minimization of cost and no efﬂuent generation due to recy-
cling of these catalysts (Gadekara et al., 2009; Clark, 2002;
Alizadeh et al., 2003). The applications of heterogeneous cata-lyst, especially heteropolyacids have become most important
for the development of environmentally benign chemical pro-
cesses and technologies in green chemistry (Heravi et al.,
2008; Clark, 2001; Anastas and Warner, 1998). Heteropolyac-
ids have been found to act as outstanding catalysts in elec-
trophillic transformation. They are stronger than the usual
mineral acids, such as HCl, H2SO4 and HNO3 (Heravi and
Sadjadi, 2009). Among the heteropolyacids, PTA is the most
widely used catalyst, because of its high acid strength, thermal
stabilities and low reducibilities (Devassy et al., 2004).
Benzimidazole ring plays an important heterocyclic phar-
macophore in drug discovery. These compounds carrying out
different substituents in benzimidazole structure are associated
with a wide range of biological activities including anticancer
(Kruse et al., 1989), antiviral (Townsend, 1996), antimicrobial
(Hubschwerlen et al., 1992), antihelmentic (Veerakumari and
Munuswamy, 2000), anti-inﬂammatory (Labanauskas et al.,
2000), antihistaminic (Iemura et al., 1986), proton pump
Table 2 Solvent effect on the synthesis of Schiff bases.a
Entry Solvents Time (h)b Yield (%)c
1 DMF 12 43
2 1,4-Dioxane 14 58
3 THF 8 38
4 Methanol 7 51
5 DMSO 26 60
6 Ethanol 1.5 95
a The mixture of 3-(1H-Benzimidazol-2-yl) naphthalene-2-amine
and benzaldehyde using PTA as catalyst in different solvents.
b Time to ﬁnish the reaction monitored by TLC.
c Yield refers to isolated products.
S664 V.U. Vernekar et al.inhibitor (Kuhler et al., 1988), antioxidant (Cole et al., 1974),
antihypertensive (Kubo et al., 1993) and anticoagulant
(Mederski et al., 2004) properties. These derivatives also exhi-
bit signiﬁcant activity against several viruses such as HIV (Por-
cari et al., 1998; Roth et al., 1997).
Schiff bases derived from aromatic amines and aromatic
aldehydes have a wide variety of applications in many ﬁelds,
e.g., biological, inorganic and analytical chemistry (Cimerman
et al., 2000; Singh et al., 1975; Perry et al., 1988). They are re-
ported to show characteristic biological activities including
antibacterial, antifungal, anticancer, anti-convulsant anti-
inﬂammatory activities (Jarrahpour et al., 2006; Taggi et al.,
2002a,b; Chohan et al., 2006; Pandeya et al., 1999; Pathak
et al., 2000; Samadhiya and Halve, 2001). Other applications
of Schiff’s bases include industrial synthesis of high value life
saving beta lactam Taggi et al., 2002a,b antibiotics from a class
of penicillins and cephalosporins. Owing to the importance of
PTA and in continuation of our work on the development of
eco-friendly reactions, we report synthesis of new Schiff bases
containing benzimidazole moiety with various aromatic alde-
hydes by using PTA as an eco-friendly catalyst.
2. Results and discussions
In the present protocol, we are reporting a simple method for
the synthesis of Schiff’s base from substituted 3-(1H-Ben-
zimidazol-2-yl) naphthalene-2-amine. Initially substituted
3-(1H-Benzimidazol-2-yl) naphthalene-2-amine is synthesized
by the reaction of 3-amino-2-naphthoic acid and substituted
o-phenylenediamine in the presence of PTA as catalyst to
afford substituted 3-(1H-Benzimidazol-2-yl) naphthalene-2-
amine. Later the free NH2 was condensed with various alde-
hydes to give Schiff bases. The purity of the synthesized com-
pounds was checked by performing TLC. Using optimized
reaction parameters, Schiff base derivatives (a11–a20) were
synthesized. The time required and the yield of the products
is given in Table 1. In each case, condensation of substrates oc-
curred and upon work-up, the corresponding Schiff base was
obtained. As seen in Table 1, a lot of Schiff bases were synthe-
sized using PTA as a catalyst in ethanol.
The reaction proceeds rapidly with 5 mol% of catalyst and
is complete within 2 h. In a control experiment, it was observed
that in the absence of the catalyst, reaction did not proceed
even at higher temperatures. It is of great importance that
the reaction is largely affected by the PTA catalyst. The entries
3 and 9, (Table 1) respectively, show the reaction of p-nitro-Table 1 The reaction of amine with various aldehydes
catalyzed by H3PO4.12WO3.xH2O in Ethanol.
Entry R1 Time (h) Compounds Yield (%) m.p. (C)
1 H 3 a11 83 142–144
2 2-Cl 2 a12 79 196–197
3 2-NO2 3 a13 42 140–141
4 3-Cl 2.5 a14 79 178–180
5 4-OCH3 1.5 a15 69 156–158
6 H 2 a16 83 121–122
7 4-OCH3 2 a17 66 104–106
8 2-Cl 1.5 a18 80 75–76
9 2-NO2 3 a19 46 106–108
10 3-Cl 3 a20 82 133–134benzaldehyde with 3-(1H-benzo[d]imidazole-2-yl)naphthalen-
2-amine and the reaction of p-nitro-benzaldehyde with 3-(6-
methyl-1H-benzo[d]imidazole-2-yl)naphthalen-2-amine under
reﬂux in ethanol solution with long reaction times, the corre-
sponding products were obtained in low yields. This low yield
may be related to steric hindrance in benzaldehyde accompa-
nied to electron withdrawing of nitro group on aromatic ring
of aldehyde.
In order to evaluate the effect of the solvent, reaction was
carried out with 3-(1H-Benzimidazol-2-yl) naphthalene-2-
amine and benzaldehyde using PTA as a model reaction
(Table 2). When the reaction was performed in ethanol using
PTA as catalyst, the reaction was very fast and the product
was easily isolated from the reaction mixture. The model reac-
tion was also performed using different solvents like DMF,
1,4-dioxane, THF, methanol, DMSO (Table 2). But the yields
were low and the reaction times were too long. These results
suggest that ethanol is the best solvent for this method.
The structures of the synthesized compounds were deter-
mined on the basis of their FT-IR and 1H NMR data and ele-
mental analysis. The IR spectra of the synthesized compounds
showed the presence of C‚N stretching bands around 1687–
1612 cm1 and NH stretching frequencies appear in the range
of 3435–3324 cm1 corresponding to azomethine compounds.
In the 1H NMR spectra of the target schiff’s base, the –NH
proton of imidazole ranges from 9.71–11.04 ppm. While
N‚CH proton varies from 4.38–4.57 ppm. The other protons
appeared at the expected chemical shifts.
3. Conclusions
In conclusion, a successful attempt has been made to synthe-
size Schiff’s base derivatives from corresponding substituted
3-(1H-Benzimidazol-2-yl) naphthalene-2-amine and various
aldehydes using ethanol as solvent in high yields. The method
employed is very simple and economically viable.
4. Experiments
4.1. Methods and materials
All compounds were routinely checked by thin-layer chroma-
tography (TLC) on aluminum-backed silica gel plates. Melting
points were determined with open capillary method and are
uncorrected. IR spectra were recorded on a Nicolet 5700 FT-
IR instrument (Nicolet, Madison, WI, USA) as KBr discs.
The 1H-NMR and 13C-NMR spectra were measured with a
PTA (H3PO4Æ12WO3ÆxH2O): An eco-friendly catalyst for the synthesis of new Schiff-bases containing S665Bruker-300 (Bruker Bioscience, USA), 300 MHz instrument
using DMSO as solvent and TMS as internal standard. All
chemical shifts were reported as d values (ppm). Mass spec-
trometer with ionization energy maintained at 70ev using Shi-
madzu Mass Spectrometer (LCMS) and elemental analysis
were carried out on MT-3 analyzer.
4.2. General procedure and spectral data of stage I
A mixture of o-phenylenediamine (0.01 mol) and 3-amino-nap-
thoic acid (0.01 mol) was taken in RB ﬂask, add 20 ml of 6 N
HCl and then reﬂuxed for 6 h at about 120 C. After comple-
tion of the reaction monitored by TLC (Eluent: 2:1 n-Hexane/
Ethyl acetate) the reaction mixture is poured in crushed ice and
basiﬁed with ammonia, ﬁltered and recrystallised from metha-
nol and was washed with water. Then the solid product was ﬁl-
tered off and recrystallized from DMF.
4.2.1. 3-(1H-benzo[d]imidazole-2-yl)naphthalen-2-amine (a)
Yield 76%; mp 179–180 C; IR (KBr) (mmax/cm1): 3372 (NH
of imidazole), 2913 (‚C–H); 1H NMR (300 MHz, DMSO-d6)
d 4.55 (s, 2H, NH2) 6.99 (s, 1H, Ar–H), 7.09–7.34 (s, 4H, Ar–
H), 7.50–7.77 (m, 5H, Ar–H), 10.14 (s, 1H, NH of imidazole);
13C NMR (75 MHz, DMSO) d 107.6 (Ar–C), 117.3 (Ar–C),
124.1 (Ar–C), 152.6 (C of imidazole). LC–MS: m/z 260.36
(M+). Anal. calcd for C21H15N5O3: C, 78.74; H, 5.05; N,
16.20%. Found: C, 70.71; H, 5.03; N, 16.23%.
4.2.2. 3-(6-methyl-1H-benzo[d]imidazole-2-yl)naphthalen-2-
amine (b)
Yield 64%; mp 153–155 C; IR (KBr) (mmax/cm1): 3432 (NH
of imidazole), 2923 (‚C–H), 1H NMR (300 MHz, DMSO-d6)
d 2.50 (s, 3H, CH3) 4.55 (s, 2H, NH2) 7.00 (d, 1H, Ar–H), 7.11
(s, 1H, Ar–H), 7.37–7.39 (d, 2H, Ar–H), 7.50 (s, 2H, Ar–H),
7.53–7.75 (d, 3H, Ar–H), 9.98 (s, 1H, NH of imidazole); 13C
NMR (75 MHz, DMSO) d 110.3 (Ar–C), 114.6 (Ar–C),
127.1 (Ar–C), 150.6 (C of imidazole). LC–MS: m/z 272.48
(M). Anal. calcd for C21H15N5O3: C, 79.10; H, 5.53; N,
15.37%. Found: C, 79.13; H, 5.50; N, 15.35%.
4.3. General procedure and spectral data of stage II
A mixture of substituted 3-(1H-Benzimidazol-2-yl) naphtha-
lene-2-amine (0.005 mol), various aldehydes (0.005 mol) and
PTA (5 mol%) in absolute alcohol was heated under reﬂux
for 16 h on water bath. After the completion of reaction as
indicated by TLC (Eluent: 1:1 Cyclohexane/Ethyl Acetate)
the reaction mixture was poured in crushed ice and the solid
was ﬁltered off. The product obtained was recrystallized from
1:1 DMF and Ethanol.
4.3.1. 3-(1H-benzo[d]imidazol-2-yl)-N-benzylidenenaphthalen-
2-amine (a11)
Light Green Solid, IR (KBr) (mmax/cm
1): 3373 (NH of imid-
azole), 2922 (‚C–H), 1687(C‚N); 1H NMR (300 MHz,
DMSO-d6) d 4.56 (s, 1H, N‚CH), 6.93–7.18 (d, 4H, Ar–H),
7.36–7.61 (s, 5H, Ar–H), 7.68–7.92 (s, 6H, Ar–H), 9.98 (s,
1H, NH of imidazole); 13C NMR (75 MHz, DMSO) d 116.5
(Ar–C), 124.3 (Ar–C), 128.9 (Ar–C), 150.6 (C of imidazole),
161.8 (HC‚N). LC–MS: m/z 346.23 (M). Anal. calcd for
C21H15N5O3: C, 82.97; H, 4.93; N, 12.10%. Found: C, 83.00;
H, 3.93; N, 18.17%.4.3.2. 3-(1H-benzimidazol-2-yl)-N-(2-
chlorobenzylidine)naphthalen-2-amine (a12)
Green Colored Solid, IR (KBr) (mmax/cm
1): 3373(NH of imid-
azole), 2924 (‚C–H), 1662 (C‚N); 1H NMR (300 MHz,
DMSO-d6) d 4.39 (s, 1H, N‚CH), 6.99–7.11 (d, 4H, Ar–H),
7.36–7.52(s, 4H, Ar–H), 7.74–8.14(s, 6H, Ar–H), 10.25(s, 1H,
NH of imidazole); 13C NMR (75 MHz, DMSO) d 113.3 (Ar–
C), 123.6 (Ar–C), 128.4 (Ar–C), 134.7 (C–Cl), 150.8 (C of
imidazole) 163.4 (HC‚N). LC-MS: m/z 381 (M), Anal. calcd
for C21H15N5O3: C, 75.49; H, 4.22; N, 11.00%. Found: C,
75.46; H, 4.24; N, 11.03%.
4.3.3. 3-(1H-benzimidazol-2-yl)-N-(2-nitrobenzylidene)
naphthalen-2-amine (a13)
Dark Yellow Color, IR (KBr) (mmax/cm
1): 3375 (NH of imid-
azole), 2853 (‚C–H), 1627 (C‚N), 1339 and 1570 (NO2
symm and asymm); 1H NMR (300 MHz, DMSO-d6) d 4.46
(s, 1H, N‚CH), 7.00–7.11 (d, 4H, Ar–H), 7.50–7.75 (s, 4H,
Ar–H), 7.77–7.95 (s, 6H, Ar–H), 10.13 (s, 1H, NH of imidaz-
ole); 13C NMR (75 MHz, DMSO) d 117.8 (Ar–C), 122.5 (Ar–
C), 127.4 (Ar–C), 147.7 (C–NO2), 151.1 (C of imidazole) 162.3
(HC‚N). LC–MS: m/z 392.46 (M), Anal. calcd. for
C21H15N5O3: C, 73.46; H, 4.11; N, 14.28%. Found: C, 73.48;
H, 4.13; N, 14.25%.
4.3.4. 3-(1H-benzimidazol-2-yl)-N-(3-chlorobenzylidine)
naphthalen-2-amine (a14)
Dark Green Solid, IR (KBr) (mmax/cm
1): 3374 (NH of imidaz-
ole), 2849(‚C–H), 1629 (C‚N); 1H NMR (300 MHz,
DMSO-d6) d 4.53 (s, 1H, N‚CH), 6.99–7.11 (d, 4H, Ar–H),
7.37–7.52(s, 4H, Ar–H), 7.75–7.95 (s, 6H, Ar–H), 9.79 (s,
1H, NH of imidazole); 13C NMR (75 MHz, DMSO) d 115.3
(Ar–C), 124.2 (Ar–C), 129.9 (Ar–C), 133.3 (C–Cl), 152.5 (C
of imidazole) 160.8 (HC‚N). LC–MS: m/z 379.99 (M), Anal.
calcd for C21H15N5O3: C, 75.49; H, 4.22; N, 11.00%. Found:
C, 75.47; H, 4.25; N, 10.58%.
4.3.5. 3-(1H-benzimidazol-2-yl)-N-(4-methoxybenzylidine)
naphthalen-2-amine (a15)
Green Colored Solid, IR (KBr)(mmax/cm
1): 3324 (NH of imid-
azole), 2923(‚C–H), 1629(C‚N); 1H NMR (300 MHz,
DMSO-d6) d 4.49 (s, 1H, N‚CH), 3.87 (s, 3H, O–CH3),
7.00–7.12 (d, 4H, Ar–H), 7.38–7.52(s, 4H, Ar–H), 7.78–7.89
(s, 6H, Ar–H), 10.36 (s, 1H, NH of imidazole); 13C NMR
(75 MHz, DMSO) d 58.3 (O–CH3), 112.6 (Ar–C), 122.5 (Ar–
C), 129.3 (Ar–C), 155.7 (C of imidazole) 159.8 (HC‚N).
LC–MS: m/z 378.33 (M+), Anal. calcd for C21H15N5O3: C,
79.55; H, 5.07; N, 11.13%. Found: C, 79.58; H, 5.10; N,
11.11%.
4.3.6. 3-(5-methyl-1H-benzimidazol-2-yl)-N-(benzylidene)
naphthalen-2-amine (a16)
Brown Colored Solid, IR (KBr)(mmax/cm
1): 3435 (NH of
imidazole), 2850(‚C–H); 1632 (C‚N); 1H NMR (300 MHz,
DMSO-d6) d 2.43 (s, 3H, Ar–CH3), 4.57 (s, 1H, N‚CH),
7.00–7.21 (d, 3H, Ar–H), 7.37–7.51 (s, 5H, Ar–H), 7.62–8.14
(s, 6H, Ar–H), 9.72 (s, 1H, NH of imidazole); 13C NMR
(75 MHz, DMSO) d 26.3 (Ar–CH3), 114.9 (Ar–C), 122.8
(Ar–C), 127.6 (Ar–C), 150.1 (C of imidazole) 162.5 (HC‚N).
LC–MS: m/z 360.36 (M), Anal. calcd. for C21H15N5O3: C,
83.08; H, 5.30; N, 11.63%. Found: C, 83.10; H, 5.27; N,
11.66%.
Scheme 1 Schematic representation of 3-(1H-benzo[d] imidazol-2-yl)-N- benzylidenenaphthalen-2-amine derivatives.
S666 V.U. Vernekar et al.4.3.7. 3-(5-methyl-1H-benzimidazol-2-yl)-N-(4-
methoxybenzylidene)naphthalen-2-amine (a17)
Yellow Colored Solid, IR (KBr)(mmax/cm
1): 3351 (NH of
imidazole), 2918(‚C–H), 1631 (C‚N); 1H NMR (300 MHz,
DMSO-d6) d 2.45 (d, 3H, Ar–CH3), 3.73 (s, 3H, O–CH3),
4.41 (s, 1H, N‚CH), 6.91–7.14 (d, 3H, Ar–H), 7.41–7.50 (s,
4H, Ar–H), 7.78–8.11 (s, 6H, Ar–H), 11.04 (s, 1H, NH of imid-
azole); 13C NMR (75 MHz, DMSO) d 24.8 (Ar–CH3), 56.2
(O–CH3), 116.8 (Ar–C), 124.9 (Ar–C), 128.3 (Ar–C), 150.8
(C of imidazole) 160.2 (HC‚N). LC–MS: m/z 392.21 (M+),
Anal. calcd. for C21H15N5O3: C, 79.77; H, 5.41; N, 10.73%.
Found: C, 79.80; H, 5.43; N, 10.70%.
4.3.8. 3-(5-methyl-1H-benzimidazol-2-yl)-N-(2-
chlorobenzylidene)naphthalen-2-amine (a18)
Yellow Colored Solid, IR (KBr)(mmax/cm
1): 3354 (NH of
imidazole), 2852 (‚C–H), 1631 (C‚N); 1H NMR
(300 MHz, DMSO-d6) d 2.50 (d, 3H, Ar–CH3), 4.52 (s, 1H,
N‚CH), 6.83–7.15 (d, 3H, Ar–H), 7.42–7.60 (s, 4H, Ar–H),
7.78–8.15 (s, 6H, Ar–H), 10.36 (s, 1H, NH of imidazole); 13C
NMR (75 MHz, DMSO) d 26.1 (Ar–CH3), 115.8 (Ar–C),
125.2 (Ar–C), 127.6 (Ar–C), 134.2 (C–Cl), 154.5 (C of imidaz-
ole) 162.9 (HC‚N). LC–MS: m/z 396.02 (M), Anal. calcd. for
C21H15N5O3: C, 75.85; H, 4.58; N, 10.61%. Found: C, 75.82;
H, 4.56; N, 10.64%.4.3.9. 3-(5-methyl-1H-benzimidazol-2-yl)-N-(2-
nitrobenzylidene)naphthalen-2-amine(19)
Dark Brown Solid, IR (KBr)(mmax/cm
1): 3426 (NH of imidaz-
ole), 2918 (‚C–H),1612 (C‚N), 1357 and 1528 (NO2 symm
and asymm); 1H NMR (300 MHz, DMSO-d6) d 2.51 (d, 3H,
Ar–CH3), 4.38 (s, 1H, N‚CH), 7.06–7.12 (d, 3H, Ar–H),
7.39–7.75 (s, 4H, Ar–H), 7.86–8.22 (s, 6H, Ar–H), 9.71 (s,
1H, NH of imidazole); 13C NMR (75 MHz, DMSO) d 22.3
(Ar–CH3), 113.8 (Ar–C), 124.0 (Ar–C), 127.6 (Ar–C), 149.2
(C–NO2), 152.7 (C of imidazole) 164.6 (HC‚N). LC–MS:
m/z 407.14 (M), Anal. calcd. for C21H15N5O3: C, 73.88; H,
4.46; N, 13.78%. Found: C, 73.91; H, 4.48; N, 13.75%.
4.3.10. 3-(5-methyl-1H-benzimidazol-2-yl)-N-(3-
chlorobenzylidene)naphthalen-2-amine (a20)
Black Colored Solid, IR (KBr)(mmax/cm
1): 3434 (NH of imid-
azole), 2921 (‚C–H), 1631 (C‚N); 1H NMR (300 MHz,
DMSO-d6) d 2.09 (d, 3H, Ar–CH3), 4.54 (s, 1H, N‚CH),
6.85–7.06 (d, 3H, Ar–H), 7.38–7.55 (s, 4H, Ar–H), 7.78–8.10
(s, 6H, Ar–H), 10.18 (s, 1H, NH of imidazole); 13C NMR
(75 MHz, DMSO) d 24.3 (Ar–CH3), 117.1 (Ar–C), 122.2
(Ar–C), 128.7 (Ar–C), 137.0 (C–Cl), 153.2 (C of imidazole)
164.6 (HC‚N). LC–MS: m/z 394.40 (M), Anal. calcd. for
C21H15N5O3: C, 75.85; H, 4.58; N, 10.61%. Found: C, 75.87;
H, 4.61; N, 10.59%. Scheme 1.
PTA (H3PO4Æ12WO3ÆxH2O): An eco-friendly catalyst for the synthesis of new Schiff-bases containing S667Acknowledgments
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